feed,title,long_url,short_url
Benzinga,"Apellis, Beam Ink $75M Deal To Test Base Gene Editing Against Complement Disorders",https://benzinga.com/general/biotech/21/07/21803407/apellis-beam-ink-75m-deal-to-test-base-gene-editing-against-complement-disorders,https://j.mp/3jBzI7F
